Samsung Bioepis is the biopharmaceutical arm of the Samsung Group.
Samsung Bioepis is the biopharmaceutical arm of the Samsung Group.

Samsung Bioepis to accelerate innovations in biosimilar treatments, to meet demand for affordable health care

  • The biopharmaceutical arm of Samsung Group is focusing on providing affordable health care options to patients
  • In less than a decade, Samsung Bioepis has become a key player in the sector, by expanding its biosimilars portfolio

Samsung Bioepis is the biopharmaceutical arm of the Samsung Group.
Samsung Bioepis is the biopharmaceutical arm of the Samsung Group.
READ FULL ARTICLE